-
Exploration of In Vivo T-cell Depletion protocols in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancie
Author: Chen, Hongru; Zhang, Yi; Fan, Yamin; Liu, Qianlin; Min, Wenyu; Xia, Linghui; Shi, Wei
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 4, pp. 412-427. DOI: 10.1016/j.jtct.2025.10.038
-
Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative Stud
Author: Wu, Ning; Yan, Chen-hua; Kong, Jun; Lv, Meng; Mo, Xiao-Dong; Sun, Yu-Qian; Cheng, Yi-Fei; Xu, Lan-Ping; Zhang, Xiao-Hui; Huang, Xiao-Jun; Wang, Yu
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 3020-. DOI: 10.1016/j.jtct.2025.10.029
-
Propensity Score-Matched Analysis Supports the Survival Benefits of Combination Chimeric Antigen Receptor T-Cell Therapy with Autologous Transplantation in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Insights from a Real-World Study in Chin
Author: Sheng, Kaiyu; You, Tao; Zhou, Jin; Wang, Yun; Wu, Depei; Huang, Haiwen
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 2880-. DOI: 10.1016/j.jtct.2025.11.001
-
One-Year Tear Proteomic Alterations with Topical Cyclosporine-A 0.1% Emulsion in Patients with Allogeneic Stem Cell Transplan
Author: Liu, Chang; Wang, Xinyue; Yeo, Sharon Wan Jie; Lee, Isabelle Xin Yu; Linn, Yeh Ching; Ho, Aloysius; Than, Hein; Quek, Jeffrey Kim Siang; Hwang, William Ying Khee; Lim, Francesca Lorraine Wei Inng; Zhou, Lei; Liu, Yu-Chi; Tong, Louis; Lim, Li
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 3, pp. 3040-. DOI: 10.1016/j.jtct.2025.11.017
-
Impact of HLA Alloimmunization on Availability of HLA Matched and Mismatched Unrelated Allogeneic Hematopoietic Cell Donors for Transplantation Disproportionately Impacts Female Patient
Author: Shaffer, Brian C.; Blouin, Amanda G.; Rapoport, Candice; Wells, Deborah S.; Chinapen, Stephanie; Perales, Miguel-Angel; Devine, Steven M.; Auletta, Jeffery J.; Stefanski, Heather E.; Spellman, Stephen R.; Maiers, Martin
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. -. DOI:
-
Bleximenib or Placebo in Combination with Standard Induction and Consolidation Therapy Followed By Maintenance for the Treatment of Patients with Newly Diagnosed KMT2A-Rearranged or NPM1-Mutant Acute Myeloid Leukemia Eligible for Intensive Chemotherapy: A Double-Blind phase 3 Study (HOVON 181 AML / AMLSG 37-25
Author: Raaijmakers, Marc; Dohner, Hartmut; Breems, Dimitri; Byrd, John C.; Dohner, Konstanze; Esteve, Jordi; Gjertsen, Bjorn Tore; Gradowska, Patrycja; Huls, Gerwin; Kaare, Ain; Kim, Hee-Je; Kiyoi, Hitoshi; Kontro, Mika; Krawczyk, Janusz; Lazarevic, Vladimir; Lenartova, Andrea; Mims, Alice; Refos, Jeannine M.; Rollig, Christoph; Schrade, Anika; Sikorska, Karolina; Theocharides, Alexandre; Valk, Peter; Venditti, Adriano; Wang, Jianxiang; Wei, Andrew H.; Wierzbowska, Agnieszka; Andrius-Zucenka; Ferrante, Lucille; Guttke, Christina; Langlois, Angelique; Loefgren, Christina; Packman, Kathryn; Shastri, Prathap Nagaraja; Schuier, Natasha; Thayu, Meena; Trancucci, Danielle; Lowenberg, Bob; Bullinger, Lars
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. -. DOI:
-
Camelot-2: A phase 3 Randomized, Double-Blind, Placebo-Controlled, Study of Bleximenib, Venetoclax and Azacitidine for the Treatment of Participants with Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2A rearrangements or NPM1 mutations, Who Are Ineligible for Intensive Chemotherap
Author: Jabbour, Elias; Sallman, David A.; Briseno-Toomey, Deborah; Guttke, Christina; Huang, Xiaojun; Dillon, Richard; Ferrante, Lucille; Ikesoe, Takayuki; Langlois, Angelique; Loefgren, Christina; Nachmias, Boaz; Nelson, Ayelet; Packman, Kathryn; Shastri, Prathap Nagaraja; Recher, Christian; Roboz, Gail J.; Schuier, Natasha; Thayu, Meena; Trancucci, Danielle; Zuppa, Athena; Ro, Christoph; Wei, Andrew H
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. -. DOI:
-
Long-Term Progression-Free Survival Benefit with Ciltacabtagene Autoleucel in Standard-Risk relapsed/refractory Multiple Myelom
Author: Costa, Luciano J.; Oriol, Albert; Dytfeld, Dominik; Manier, Salomon; Voorhees, Peter M.; Lin, Yi; Htut, Myo; Roeloffzen, Wilfried; Ho, Phoebe Joy; Shah, Urvi A.; Zhao, Man; Li, Quanlin; Balogh, Agnes; Li, Katherine; Slaughter, Ana; Benachour, Nina; Lonardi, Carolina; Ghosh, Arnab; Sun, Huabin; Lendvai, Nikoletta; Lengil, Tamar; Patel, Nitin; Koneru, Mythili; Florendo, Erika; Filho, Octavio Costa; Mahajan, Vrinda; Rodriguez-Otero, Paula; Strouse, Christopher; Stewart, A. Keith; Sidana, Surbhi
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2026; Vol. 32, Issue 2, pp. -. DOI:
